
Ensysce Biosciences (NASDAQ:ENSC) Receives U.S. Patent for Groundbreaking Treatment of Opioid Use Disorder
~ Applies TAAP and MPAR Technology to Produce Novel OUD Treatments ~ ~ Prioritizes Safety and Tolerability for OUD Patients ~ SAN DIEGO, CA April 23, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) (“Ensysce” or the “Company”), […]